Q2 2025 · 13F-HR
BOONE CAPITAL MANAGEMENT LLCholdings as filed
Filed 2025-08-14 · accession 0001214659-25-012210
$233.2M
Reported value
11
Positions
2025-06-30
Period end
The Brief · BOONE CAPITAL MANAGEMENT LLC · Q2 2025
AI · grounded in 13F
BOONE CAPITAL MANAGEMENT LLC established a new position in MEDTRONIC PLC valued at $37.4M. The fund also initiated stakes in MIRM for $32.6M and BMRN for $24.6M. Other new additions include AVTR at $22.8M, UNM at $22.8M, and NBIX at $22.7M. The fund ended the period with 11 positions and total AUM of $233.2M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G5960L103 | MDT | MEDTRONIC PLC | $37.4M | 16.0% | 428,789 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $32.6M | 14.0% | 641,448 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $24.6M | 10.5% | 447,449 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $22.8M | 9.78% | 1,694,482 | Common | SOLE |
| 91529Y106 | UNM | UNUM GROUP | $22.8M | 9.76% | 281,790 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $22.7M | 9.72% | 180,338 | Common | SOLE |
| 70805E109 | PNTG | PENNANT GROUP INC | $19.4M | 8.31% | 649,022 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $18.1M | 7.77% | 58,112 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $13.9M | 5.98% | 95,832 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $11.8M | 5.05% | 35,600 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $7.1M | 3.06% | 1,254,658 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.